Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 27;42(1):37.
doi: 10.1007/s12032-024-02589-x.

Unraveling non-coding RNAs in breast cancer: mechanistic insights and therapeutic potential

Affiliations
Review

Unraveling non-coding RNAs in breast cancer: mechanistic insights and therapeutic potential

Muqtada Shaikh et al. Med Oncol. .

Abstract

Breast cancer remains a leading global health challenge requiring innovative, therapeutic strategies to improve patient outcomes. This review explores the pivotal roles of non-coding RNAs (ncRNAs), including long non-coding RNA, micro RNA, and circular RNA, in breast cancer biology. We highlight how these molecules regulate critical signaling pathways, influence tumor microenvironments, and contribute to treatment resistance. Our findings underscore the potential of ncRNAs as biomarkers for early diagnosis and as treatment targets for personalized treatment strategies. To pave the way for innovative cancer management approaches, we investigate the complex interactions of ncRNAs and their impact on tumor progression. This comprehensive review enhances our understanding of breast cancer biology while emphasizing the translational significance of ncRNA research in developing effective treatment strategies. Additional research and clinical studies are required to confirm the diagnostic and medicinal value of ncRNAs in breast cancer. Investigating the complex networks of ncRNA interactions and their links to other biological pathways can lead to the discovery of new treatment targets. Furthermore, leveraging advanced technologies, such as machine learning and multi-omics methods, will be critical in improving our understanding of ncRNAs biomarkers and translating these insights into impactful clinical applications.

Keywords: Breast cancer; Circular RNA; Long non-coding RNA; Micro RNA; Non-coding RNAs; Targeted therapy.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interest: The authors declare no competing interests.

Similar articles

Cited by

References

    1. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15–23. - PubMed - PMC
    1. Masoud V, Pagès G. Targeted therapies in breast cancer: new challenges to fight against resistance. World J Clin Oncol. 2017;8:120. - PubMed - PMC
    1. Yardim-Akaydin S, Karahalil B, Baytas SN. New therapy strategies in the management of breast cancer. Drug Discov Today. 2022;27:1755–62. - PubMed
    1. Lanfranchi AEFP. Breast cancer and induced abortion: a comprehensive review of breast development and pathophysiology, the epidemiologic literature, and proposal for creation of databanks to elucidate all breast cancer risk factors. Law Med. 2014;29:3–133.
    1. Caldon CE, Daly RJ, Sutherland RL, Musgrove EA. Cell cycle control in breast cancer cells. J Cell Biochem. 2006;97:261–74. - PubMed

MeSH terms

LinkOut - more resources